Oscar Health, Inc. (NYSE:OSCR – Get Free Report) shares reached a new 52-week low on Thursday . The company traded as low as $12.85 and last traded at $12.54, with a volume of 1260755 shares. The stock had previously closed at $13.76.
Analyst Ratings Changes
OSCR has been the subject of a number of recent research reports. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group began coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price for the company. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Oscar Health presently has a consensus rating of “Hold” and an average target price of $21.56.
Oscar Health Stock Up 2.6 %
Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts predict that Oscar Health, Inc. will post 0.91 EPS for the current fiscal year.
Insider Activity
In related news, insider Mario Schlosser sold 6,516 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $117,809.28. Following the completion of the transaction, the insider now owns 81,962 shares in the company, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Steven Wolin sold 19,580 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the transaction, the chief operating officer now owns 102,598 shares of the company’s stock, valued at $1,854,971.84. The trade was a 16.03 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 103,610 shares of company stock worth $1,847,519 over the last quarter. 25.11% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in OSCR. Creative Planning boosted its holdings in Oscar Health by 75.3% during the second quarter. Creative Planning now owns 18,010 shares of the company’s stock worth $285,000 after purchasing an additional 7,736 shares during the last quarter. nVerses Capital LLC raised its position in Oscar Health by 36.1% during the third quarter. nVerses Capital LLC now owns 18,100 shares of the company’s stock worth $384,000 after acquiring an additional 4,800 shares in the last quarter. Optimum Investment Advisors bought a new stake in Oscar Health during the third quarter worth $142,000. Allspring Global Investments Holdings LLC raised its position in Oscar Health by 1.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 109,074 shares of the company’s stock worth $2,313,000 after acquiring an additional 1,866 shares in the last quarter. Finally, Toth Financial Advisory Corp raised its position in Oscar Health by 73,185.7% during the third quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company’s stock worth $1,088,000 after acquiring an additional 51,230 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Read More
- Five stocks we like better than Oscar Health
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- How to Buy Cheap Stocks Step by Step
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- What Do S&P 500 Stocks Tell Investors About the Market?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.